We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Astellas Pharma Inc | TG:YPH | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
-0.17 | -1.90% | 8.768 | 200 | 16:22:53 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
8.758 | 8.95 | 8.768 | 8.768 | 8.768 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
09:00:42 | 200 | 8.768 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
22/4/2024 | 20:41 | ALNC | Takeda, Astellas and Sumitomo to create new drug discovery company |
11/3/2024 | 15:37 | ALNC | IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba |
11/3/2024 | 13:16 | ALNC | *Astellas: FDA grants drug exclusivity to Cresemba aspergillosis,.. |
20/2/2024 | 21:15 | ALNC | Merck and Astellas drugs get priority review in US and Japan |
29/1/2024 | 08:26 | ALNC | Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer |
18/12/2023 | 11:04 | ALNC | Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev |
08/12/2023 | 20:07 | ALNC | IN BRIEF: Astellas Pharma announces US FDA green light for Cresemba |
Astellas Pharma (YPH) Share Charts1 Year Astellas Pharma Chart |
|
1 Month Astellas Pharma Chart |
Intraday Astellas Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions